Investors

Insider Transactions

Date Name Title Type Shares Traded Sorted Ascending Price Range
Dec 17, 2012 goldberg murray a Officer Option Execute 1,850 20.32
Mar 30, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,852 n/a
Jul 12, 2012 vagelos p roy Officer Disposition (Non Open Market) 1,860 n/a
Nov 17, 2014 goldberg murray a Officer Disposition (Non Open Market) 1,930 n/a
Oct 25, 2012 brown michael s Director Option Execute 2,000 23.84
Nov 24, 2014 brown michael s Director Disposition (Non Open Market) 2,000 n/a
Oct 25, 2012 brown michael s Director Sell 2,000 155.34
Mar 17, 2014 brown michael s Director Automatic Sell 2,000 333.42 - 336.49
Mar 17, 2014 brown michael s Director Option Execute 2,000 33.42
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Nov 17, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Jan 2, 2009 gilman alfred g Director Acquisition (Non Open Market) 2,000 n/a
Jan 2, 2009 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Aug 6, 2014 goldstein joseph l Director Sell 2,000 331.20
Aug 14, 2014 goldstein joseph l Director Sell 2,000 347.65
Aug 27, 2014 goldstein joseph l Director Sell 2,000 350.31
Aug 4, 2015 goldstein joseph l Director Automatic Sell 2,000 586.00
Jun 22, 2015 goldstein joseph l Director Automatic Sell 2,000 526.85
Jul 15, 2015 goldstein joseph l Director Automatic Sell 2,000 550.00
May 18, 2012 shooter eric m Director Sell 2,000 124.04
Showing 81-100 of 974 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)